A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools
A new series of cyanoacrylamides incorporating sulphamethoxazol were prepared and confirmed by different spectral tools. Anticancer screening of the new compounds was done against three different types of carcinoma cell lines involving (A549, HCT116, and MDA) using MTT assay. Compound 7 among all te...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878535220301453 |
id |
doaj-b461ee3efe784818bc6283c89fecfc83 |
---|---|
record_format |
Article |
spelling |
doaj-b461ee3efe784818bc6283c89fecfc832020-11-25T03:28:15ZengElsevierArabian Journal of Chemistry1878-53522020-07-0113759785995A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular toolsMagda F. Mohamed0Heba K.A. Elhakim1Amna A. Saddiq2Ismail A. Abdelhamid3Department of Chemistry (Biochemistry Branch), Faculty of Science, Cairo University, Giza, Egypt; Department of Chemistry, Faculty of Science and Arts, Khulais, University of Jeddah, Saudi Arabia; Corresponding authors.Department of Chemistry (Biochemistry Branch), Faculty of Science, Cairo University, Giza, EgyptDepartment of Biology, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia; Chair of Yousef Abdulatif Jameel of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Chemistry, Faculty of Science, Cairo University, Giza, Egypt; Corresponding authors.A new series of cyanoacrylamides incorporating sulphamethoxazol were prepared and confirmed by different spectral tools. Anticancer screening of the new compounds was done against three different types of carcinoma cell lines involving (A549, HCT116, and MDA) using MTT assay. Compound 7 among all tested derivatives achieved the best cytotoxic effect against all tested carcinoma cell lines. HCT116 revealed the best sensitivity and cytotoxic activity toward compound 7 relative to 5-FU. The target compound offered less toxic effect when tested on normal melanocytes (HFB4). Simulation modeling studies revealed strong binding affinity toward the following domains (1dls, 2c6o, and 2wgj) and moderate binding modes toward (3eyl, 4kmp, 2w3l, and 5lab) domains with different binding energy scores. Gene expression profile outlined that caspase-3, BAX, and P53 genes were strongly upregulated relative to their control, while BCL2, MMP1, and CDK2 were effectively down regulated assuming the activation of the apoptotic pathway. Flow cytometry technique revealed that compound 7 stimulated cell cycle arrests at the G2/M phase. Other extensive molecular diagnostic tools were utilized in this report as ELISA, DPA, SEM, and TEM assays which confirmed that our target novel compound 7 was a very promising and interesting chemotherapeutic agent with less toxic effect. Also, authors herein suggested that additional sulphamethoxazole linked to 3-(1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)acrylonitrile in compound 7 was responsible for its promising cytotoxic activity against colorectal carcinoma cell line.http://www.sciencedirect.com/science/article/pii/S1878535220301453Colorectal carcinomaCyanoacrylamidesSulphamethoxazoleCytotoxicityModeling studiesApoptosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Magda F. Mohamed Heba K.A. Elhakim Amna A. Saddiq Ismail A. Abdelhamid |
spellingShingle |
Magda F. Mohamed Heba K.A. Elhakim Amna A. Saddiq Ismail A. Abdelhamid A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools Arabian Journal of Chemistry Colorectal carcinoma Cyanoacrylamides Sulphamethoxazole Cytotoxicity Modeling studies Apoptosis |
author_facet |
Magda F. Mohamed Heba K.A. Elhakim Amna A. Saddiq Ismail A. Abdelhamid |
author_sort |
Magda F. Mohamed |
title |
A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools |
title_short |
A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools |
title_full |
A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools |
title_fullStr |
A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools |
title_full_unstemmed |
A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools |
title_sort |
novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of hct116 cell line by different molecular tools |
publisher |
Elsevier |
series |
Arabian Journal of Chemistry |
issn |
1878-5352 |
publishDate |
2020-07-01 |
description |
A new series of cyanoacrylamides incorporating sulphamethoxazol were prepared and confirmed by different spectral tools. Anticancer screening of the new compounds was done against three different types of carcinoma cell lines involving (A549, HCT116, and MDA) using MTT assay. Compound 7 among all tested derivatives achieved the best cytotoxic effect against all tested carcinoma cell lines. HCT116 revealed the best sensitivity and cytotoxic activity toward compound 7 relative to 5-FU. The target compound offered less toxic effect when tested on normal melanocytes (HFB4). Simulation modeling studies revealed strong binding affinity toward the following domains (1dls, 2c6o, and 2wgj) and moderate binding modes toward (3eyl, 4kmp, 2w3l, and 5lab) domains with different binding energy scores. Gene expression profile outlined that caspase-3, BAX, and P53 genes were strongly upregulated relative to their control, while BCL2, MMP1, and CDK2 were effectively down regulated assuming the activation of the apoptotic pathway. Flow cytometry technique revealed that compound 7 stimulated cell cycle arrests at the G2/M phase. Other extensive molecular diagnostic tools were utilized in this report as ELISA, DPA, SEM, and TEM assays which confirmed that our target novel compound 7 was a very promising and interesting chemotherapeutic agent with less toxic effect. Also, authors herein suggested that additional sulphamethoxazole linked to 3-(1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)acrylonitrile in compound 7 was responsible for its promising cytotoxic activity against colorectal carcinoma cell line. |
topic |
Colorectal carcinoma Cyanoacrylamides Sulphamethoxazole Cytotoxicity Modeling studies Apoptosis |
url |
http://www.sciencedirect.com/science/article/pii/S1878535220301453 |
work_keys_str_mv |
AT magdafmohamed anovelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT hebakaelhakim anovelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT amnaasaddiq anovelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT ismailaabdelhamid anovelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT magdafmohamed novelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT hebakaelhakim novelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT amnaasaddiq novelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools AT ismailaabdelhamid novelinhibitor2cyano31phenyl3thiophen2ylpyrazol4ylacrylamidelinkedtosulphamethoxazoleblocksantiapoptoticproteinsviamoleculardockingandstronglyinducedapoptosisofhct116celllinebydifferentmoleculartools |
_version_ |
1724585352118665216 |